MedTrace's PET water device used to dose U.S. patient June 9, 2023 -- Danish PET technology developer MedTrace said that the first U.S. patient has been scanned in a phase III clinical trial involving its point-of-care manufacturing and dosing system for oxygen-15 water.Read More
DeepTek.ai nets FDA nod for workflow software June 9, 2023 -- Radiology AI software developer DeepTek.ai of Maharashtra, India, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Augmento AI-powered radiology workflow management software.Read More
Turing debuts MRI visual feedback module at ISMRM 2023 June 9, 2023 -- Neuroimaging software company Turing Medical Technologies (formerly Nous Imaging) used the venue of ISMRM 2023 in Toronto to launch FIRMM-pix, an in-bore visual feedback module designed to actively reduce head motion during brain MRI scans.Read More
Hyperfine partners with the ISMRM, Gates Foundation June 9, 2023 -- Portable MRI developer Hyperfine is collaborating with the International Society for Magnetic Resonance in Medicine (ISMRM) and the Bill & Melinda Gates Foundation on an educational program to increase neuroimaging clinical research and knowledge transfer between high-income and low- and medium-income countries.Read More
Teleflex gets FDA nod for MR-conditional labeling June 8, 2023 -- Medical device developer Teleflex has received U.S. Food and Drug Administration 510(k) clearance for MR-conditional labeling on its Arrow EZ-IO intraosseous needle.Read More
SpectronRx, RLS ink radiopharmaceutical supply deal June 8, 2023 -- Radiopharmaceutical manufacturer SpectronRx and nuclear medicine drug distributor RLS are collaborating in an effort to enhance the supply and availability of diagnostic and therapeutic radiopharmaceuticals.Read More
MITA chides CMS on beta-amyloid PET decision June 7, 2023 -- The Medical Imaging and Technology Alliance (MITA) has expressed concern over the U.S. Centers for Medicare and Medicaid Services' (CMS) decision not to include coverage for beta-amyloid PET imaging as part of a new plan to cover Alzheimer's disease drugs.Read More
Check-Cap lays off 90% of workforce June 7, 2023 -- Israeli firm Check-Cap, a developer of an investigational swallowable low-dose x-ray capsule for colon cancer screening, is reevaluating its strategic business plan and has laid off 90% of its staff.Read More